عربي
Theramex Reinforces its Commitment to Women on International Women’s Day
LONDON -Wednesday 9 February 2022 
We have partnered with amazing organisations to celebrate this special day Our campaigns allow us to work harder than ever to improve women's lives Internal communication and campaigns are a vital part in the support of women (BUSINESS WIRE)-- International Women’s Day is an...
Theramex Enters OTC Market with Femarelle®, a Non-hormonal Option to Treat Menopause Symptoms
-Tuesday 16 November 2021
(BUSINESS WIRE)-- Theramex, a company dedicated women’s health, recently acquired the Femarelle® product licence to treat menopause symptoms. Femarelle will be available in different markets from the 2nd quarter of 2022. This commercialisation agreement was reached with Se-cure...
Theramex Appoints Sigurd Kirk to the Board of Directors -Monday 12 July 2021
(BUSINESS WIRE)-- Theramex, a CVC Capital Partners ("CVC") portfolio company focused on Women’s Health has announced that Sigurd (Sig) Kirk has been appointed as a member of the Board of Directors for Theramex. Theramex is a leading global speciality pharmaceutical company dedicated to women...
Theramex Launches New Website
-Tuesday 2 March 2021
The aim of the new website is to become a reference of rigorous and useful information on menopause, osteoporosis, fertility and contraception. The new website contains up-to-date therapy area information for both HCPs and general public. The local websites will include more detailed...
Permalink :- http://aetoswire.com/newsroom/1/theramex